Features & Benefits

ICC an unique combination anti-inflammatory compounds for chronic inflammatory diseases. ICC reduces various inflammatory mediators such as interleukin-6 (IL-6), IL-1 beta, TNF-alpha, prostaglandin E2 and leukotrienes.

Actions

-Reduces various inflammatory mediators
-Including: interleukin-6 (IL-6), IL-1 beta, TNF-alpha, prostaglandin E2 and leukotrienes

Indications

-Chronic Inflammation
-Rheumatoid & osteoarthritis
-Ulcerative colitis
-Crohn’s disease
-Eczema
-SLE
-Cancer Protocols
-Lung cancer
-Breast Cancer
-Colorectal Cancer
-Inflammation induced angiogenesis